Tempus Ai, Inc. bought PSNL once, on Nov 18, 2025
10% owner at Personalis, Inc.
SEC CIK 0001717115 · Filings on SEC.gov ↗
Tempus Ai, Inc.'s record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
1 filing since Feb 2026, newest first
About Tempus Ai, Inc.
Tempus AI, Inc. is a healthcare technology company specializing in precision medicine and artificial intelligence, founded in 2015 by Eric Lefkofsky in Chicago following his wife's breast cancer diagnosis.( Initially focused on oncology, the company aggregates vast clinical and molecular data from over 2,000 healthcare institutions to enable AI-driven personalized treatments, expanding into cardiology, neuropsychology, and other areas, with a library of multimodal data supporting drug discovery and clinical trials.(
Tempus, formerly Tempus Labs, has raised over $1 billion in funding, achieving an $8 billion valuation by 2021, and employs around 2,400 people as of 2024.( Led by CEO Eric Lefkofsky—a serial entrepreneur and Groupon co-founder—the company reported $500 million in revenue by 2022, invests heavily in R&D ($150 million annually), and partners with over 1,000 hospitals.( As a corporate insider, Tempus AI recently traded 10% in Personalis, Inc. (PSNL), reflecting its active role in healthcare investments.
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.